CoChat

The immune system, amyloid‐β peptide, and Alzheimer's disease

Weksler, Marc E., Gouras, Gunnar, Relkin, Norman R., Szabo, Paul · 2005 · Immunological Reviews
Cited by 60

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Summary: In this review, the case is made that amyloid‐β peptide in the brain of patients with Alzheimer's disease is a primary cause of the disease and that immunotherapy directed against this peptide has the potential to halt and/or reverse disease progression. This supposition is supported by the capacity of anti‐β‐amyloid peptide antibodies to prevent or reverse the disease in mouse models of Alzheimer's disease. Furthermore, preliminary results obtained in a small number of patients with Alzheimer's disease are consistent with the observations made in the mouse model of this disease. We review the relationship between the immune system, amyloid‐β peptide, and Alzheimer's disease and the progress made in applying immunotherapy to patients with Alzheimer's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.0105-2896.2005.00264.x

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 60

Metadata

Authors
Weksler, M. E., Gouras, G., Relkin, N. R., & Szabo, P.
Venue
Immunological Reviews
Publisher
Wiley
Published
2005-05-09
Volume
205
Issue
1
Pages
244-256
ISSN
  • 0105-2896 (ISSN-L)
  • 1600-065X
OpenAlex
W1974115513
Cited by
60
References
28
FWCI
0.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The immune system, amyloid‐β peptide, and Alzheimer's disease. https://app.cochat.ai/papers/10.1111/j.0105-2896.2005.00264.x
The paper
Weksler, M. E., Gouras, G., Relkin, N. R., & Szabo, P. (2005). The immune system, amyloid‐β peptide, and Alzheimer's disease. Immunological Reviews. https://doi.org/10.1111/j.0105-2896.2005.00264.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.